THCV – Weight Management


Senior-High is proud to introduce its first privately-labeled product, THCV formulated with Biovarin™ for weight management support. BioVarin is a carefully formulated product that aims to support healthy lifestyle choices, including maintaining a balanced weight, promoting appetite control, and supporting blood sugar management. Leafly has referred to THCV as “a fascinating compound that’s sure to make major waves in the cannabis world as we discover and utilize its full potential.” This product is all-natural, preservative-free, dairy-free, gluten-free, and sugar-free.


  • Appetite Control: THCV is known for its ability to curb hunger and reduce cravings, making it easier to stick to a weight loss plan and avoid temptation 1
  • Energy Boost: Feel more energized throughout the day with THCV’s natural energy-enhancing properties, allowing one to tackle workouts and daily tasks with ease 1
  • Metabolism Support: These capsules are formulated to aid metabolism, promoting efficient calorie burning and weight management 1
  • Quality, Purity, and Consistency: We take pride in our commitment to quality and purity. Our capsules are crafted using the highest-quality ingredients and are microencapsulated in Bio-Dri™ to ensure a highly bioavailable and effective product you can trust 2
  • Our expertly formulated capsules are designed to have a positive impact on blood sugar control and insulin sensitivity

Note: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Info Sheet

60 capsules / bottle


1.  Wargent ET, Zaibi MS, Silvestri C, Hislop DC, Stocker CJ, Stott CG, Guy GW, Duncan M, Di Marzo V, Cawthorne MA. The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutr Diabetes. 2013 May 27;3(5):e68. doi: 10.1038/nutd.2013.9. PMID: 23712280; PMCID: PMC3671751

2. Silvestri C, Paris D, Martella A, Melck D, Guadagnino I, Cawthorne M, Motta A, Di Marzo V. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. J Hepatol. 2015 Jun;62(6):1382-90. doi: 10.1016/j.jhep.2015.01.001. Epub 2015 Jan 13. PMID: 25595882

Pin It on Pinterest